• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Antitumor activity and toxicity of cisplatin analogs.

作者信息

Rose W C, Schurig J E, Huftalen J B, Bradner W T

出版信息

Cancer Treat Rep. 1982 Jan;66(1):135-46.

PMID:7198010
Abstract
摘要

相似文献

1
Antitumor activity and toxicity of cisplatin analogs.顺铂类似物的抗肿瘤活性和毒性。
Cancer Treat Rep. 1982 Jan;66(1):135-46.
2
Reduced antineoplastic activity in mice of cisplatin administered with high salt concentration in the vehicle.在载体中以高盐浓度给药的顺铂在小鼠体内的抗肿瘤活性降低。
J Natl Cancer Inst. 1984 Sep;73(3):743-52.
3
Biological evaluation of mitoxantrone dihydrochloride synthesized by a new method. II. Comparison of Now 85/34 and Novantrone (Lederle) acute toxicity and antitumor activity.
Arch Immunol Ther Exp (Warsz). 1989;37(1-2):89-99.
4
Relative pulmonary toxicity and antitumor effects of two new bleomycin analogs, pepleomycin and tallysomycin A.两种新的博来霉素类似物，平阳霉素和 tallysomycin A 的相对肺毒性和抗肿瘤作用。
Cancer Treat Rep. 1980 Apr-May;64(4-5):659-67.
5
[Complex compounds of platinum in the chemotherapy of malignant tumors].[铂的复合化合物在恶性肿瘤化疗中的应用]
Vestn Akad Med Nauk SSSR. 1979(2):68-80.
6
Antitumor activity of N-diazoacetyl derivatives of glycine and phenylalanine against P388 leukemia and B16 melanoma in mice.甘氨酸和苯丙氨酸的N-重氮乙酰基衍生物对小鼠P388白血病和B16黑色素瘤的抗肿瘤活性。
Cancer Treat Rep. 1982 Jan;66(1):179-81.
7
Chemotherapy studies on experimental mouse tumors. IX.实验小鼠肿瘤的化疗研究。IX.
Cancer Chemother Rep 2. 1971 Apr;2(1):177-97.
8
Therapeutic response of human tumor xenografts in athymic mice to doxorubicin.无胸腺小鼠体内人肿瘤异种移植对阿霉素的治疗反应
Cancer Res. 1981 Jan;41(1):325-35.
9
[Synthesis of rubomycin 13-tert-butoxycarbonylhydrazone and the study of its antitumor action].柔红霉素13-叔丁氧羰基腙的合成及其抗肿瘤作用研究
Antibiotiki. 1981 Nov;26(11):813-6.
10
Structure-activity relationships of the antitumor platinum coordination complexes.
Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1499-502.

引用本文的文献

1
Unveiling the chemotherapeutic potential of two platinum(IV) complexes in skin cancer: Insights.揭示两种铂（IV）配合物在皮肤癌中的化疗潜力：见解。
Curr Res Pharmacol Drug Discov. 2024 Oct 26;7:100205. doi: 10.1016/j.crphar.2024.100205. eCollection 2024.
2
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.下一代铂类药物：靶向铂（II）剂、纳米颗粒递送及铂（IV）前药
Chem Rev. 2016 Mar 9;116(5):3436-86. doi: 10.1021/acs.chemrev.5b00597. Epub 2016 Feb 11.
3
Emerging drug treatments for solid tumours.
实体瘤的新兴药物治疗方法。
Drugs. 1996 Jan;51(1):45-72. doi: 10.2165/00003495-199651010-00005.
4
Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in rats.卡铂和顺铂联合全身热疗对大鼠的血液学毒性
Br J Cancer. 1993 Sep;68(3):469-74. doi: 10.1038/bjc.1993.372.
5
Differential antitumor activity and toxicity of isomeric 1,2-diaminocyclohexane platinum (II) complexes.异构1,2-二氨基环己烷铂（II）配合物的抗肿瘤活性和毒性差异
J Cancer Res Clin Oncol. 1993;120(1-2):12-6. doi: 10.1007/BF01200718.
6
Antitumor activity of isomeric 1,2-diaminocyclohexane platinum(IV) complexes.同分异构的1,2-二氨基环己烷铂（IV）配合物的抗肿瘤活性
J Cancer Res Clin Oncol. 1994;120(7):409-14. doi: 10.1007/BF01240140.
7
Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.新型氨/胺铂（IV）二羧酸盐在对顺铂、四铂或卡铂敏感及耐药的L1210小鼠白血病细胞中的评估
Br J Cancer. 1994 Sep;70(3):415-20. doi: 10.1038/bjc.1994.320.
8
Ammine/amine platinum (II) complexes effective in vivo against murine tumors sensitive or resistant to cisplatin and tetraplatin.氨/胺铂（II）配合物在体内对顺铂和四铂敏感或耐药的小鼠肿瘤有效。
J Cancer Res Clin Oncol. 1994;120(10):571-7. doi: 10.1007/BF01212810.
9
New cisplatin analogues in development. A review.正在研发的新型顺铂类似物。一篇综述。
Drugs. 1993 Sep;46(3):360-377. doi: 10.2165/00003495-199346030-00003.
10
A phase I trial of cis-diammine-1,1-cyclobutane dicarboxylate platinum II (Carboplatin, CBDCA, JM-8) with a single dose every five week-schedule.
Invest New Drugs. 1984;2(3):297-304. doi: 10.1007/BF00175380.